Lars Bevanger
Impact in
- Endocrinology top 2%
- Escherichia coli research studies
- Infectious Diseases top 5%
- Viral gastroenteritis research and epidemiology
- Antifungal resistance and susceptibility
- Antimicrobial Resistance in Staphylococcus
Papers in
-
- Neonatal and Maternal Infections 18
- Streptococcal Infections and Treatments 17
-
- Antimicrobial Resistance in Staphylococcus 5
- Viral gastroenteritis research and epidemiology 3
- Co-authors
- Kåre Bergh (6 shared papers)Jan Egil Afset (3 shared papers)Peter Gaustad (3 shared papers)Asbjørn Digranes (3 shared papers)Hanne H. Haukland (2 shared papers)Per Sandven (2 shared papers)Pål Romundstad (1 shared paper)Ole‐Jan Iversen (5 shared papers)
In The Last Decade
Lars Bevanger
33 papers receiving 888 citations
Peers
Comparison fields: 5 of 58
- Endocrinology 303
- Infectious Diseases 536
- Molecular Medicine 70
- Public Health, Environmental and Occupational Health 338
- Applied Microbiology and Biotechnology 23
Countries citing papers authored by Lars Bevanger
This map shows the geographic impact of Lars Bevanger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Bevanger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Bevanger more than expected).
Fields of papers citing papers by Lars Bevanger
This network shows the impact of papers produced by Lars Bevanger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Bevanger. The network helps show where Lars Bevanger may publish in the future.
Co-authors
The 25 scholars most cited alongside Lars Bevanger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 148 | |
| 2 | 2006 | 120 | |
| 3 | 2004 | 112 | |
| 4 | 1998 | 71 | |
| 5 | 2003 | 66 | |
| 6 | 1985 | 44 | |
| 7 | 1979 | 42 | |
| 8 | 1983 | 39 | |
| 9 | 1977 | 37 | |
| 10 | 1985 | 24 | |
| 11 | 1995 | 22 | |
| 12 | Distribution of PFGE types of invasive Norwegian group B streptococci in relation to serotypes. | 2004 | 20 |
| 13 | 2002 | 20 | |
| 14 | 1992 | 19 | |
| 15 | 1981 | 19 | |
| 16 | 1985 | 17 | |
| 17 | 2001 | 17 | |
| 18 | 1991 | 13 | |
| 19 | 1999 | 12 | |
| 20 | 2004 | 12 |
About Lars Bevanger
Lars Bevanger is a scholar working on Public Health, Environmental and Occupational Health, Infectious Diseases, Epidemiology, Microbiology and Surgery, having authored 33 papers that have together received 942 indexed citations. Recurring topics across this work include Neonatal and Maternal Infections (18 papers), Streptococcal Infections and Treatments (17 papers), Pneumonia and Respiratory Infections (9 papers), Antimicrobial Resistance in Staphylococcus (5 papers), Bacterial Infections and Vaccines (4 papers), Bacterial Identification and Susceptibility Testing (3 papers), Escherichia coli research studies (3 papers) and Viral gastroenteritis research and epidemiology (3 papers). The work is most often cited by research in Endocrinology (303 citations), Infectious Diseases (536 citations), Molecular Medicine (70 citations), Public Health, Environmental and Occupational Health (338 citations) and Applied Microbiology and Biotechnology (23 citations). Lars Bevanger has collaborated with scholars based in Norway, Sweden and Poland. Frequent co-authors include Kåre Bergh, Jan Egil Afset, Peter Gaustad, Asbjørn Digranes, Hanne H. Haukland, Per Sandven, Pål Romundstad, Ole‐Jan Iversen, Turid Mannsåker and Guillaume Bruant. Their work appears in journals such as Apmis, Journal of Clinical Microbiology, Advances in experimental medicine and biology, Journal of Medical Microbiology and Clinical and Vaccine Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.